O85 SHOULD WE AWAIT INTERFERON-FREE REGIMENS TO TREAT HCV GENOTYPE 1 TREATMENT-NAIVE PATIENTS? A COST-EFFECTIVENESS ANALYSIS (ANRS 12188).

Authors :: Deuffic-Burban, S.
Schwarzinger, M.
Obach, D.
Mallet, V.
Pol, S.
Pageaux, G.-P.
Canva, V.
Deltenre, P.
Roudot-Thoraval, F.
Larrey, D.
Dhumeaux, D.
Mathurin, P.
Yazdanpanah, Y.
Source :: Journal of Hepatology. Apr2014 Supplement, Vol. 60, pS35-S35. 1p.
Publication Year :: 2014

Subjects :: *HEPATITIS C treatment
*THERAPEUTIC use of interferons
*GENOTYPES
*COST effectiveness
*HEPATITIS C
*MEDICAL care costs
*PATIENTS

Full Text Access

Tools